Advertisement

Search Results

Advertisement



Your search for Milena Sant, MD matches 4 pages

Showing 1 - 4


global cancer care

Milena Sant, MD, on The Latest Findings From the EUROCARE 5 Study

Milena Sant, MD, of Istituto Nazionale dei Tumori, discusses the question of whether Europe is doing better in cancer care since the 1990s (Abstract LBA1).

survivorship

Cancer Survival Improves in Europe, With Wide Regional Variations

EUROCARE-5, the latest in a series of comprehensive reports on the state of cancer survival in Europe, shows an improvement in 5-year survival from 1998 to 2007, with large variations among regions of Europe, according to a presentation at the European Cancer Congress.1 Furthermore, although 5-year ...

survivorship
issues in oncology
issues in oncology

ECC 2015: EUROCARE Results Show Large Variations in Survival Among European Countries

Comparisons of cancer patients’ survival and care in Europe up to 2007 showed that although more patients are surviving for at least 5 years after diagnosis, there are large variations among countries, which are particularly significant in cancers of the blood. Milena Sant, MD, from the...

hematologic malignancies

Improved Survival in Hematologic Malignancies in Europe Between 1997 and 2008

As reported by Sant et al in The Lancet Oncology, the population based EUROCARE-5 study has shown significantly improved survival in hematologic malignancies in Europe between 1997 and 2008. Although improved, survival was poorer in Eastern Europe compared with other regions. Study Details This...

Advertisement

Advertisement



Advertisement